{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:44:41Z","timestamp":1788576281584,"version":"build-2803163510"},"reference-count":231,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Allakos"},{"name":"Aralez"},{"name":"FAES"},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uriach"},{"name":"Allakos"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uriach"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jaci.2019.07.017","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T18:59:27Z","timestamp":1564426767000},"page":"S19-S30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"S","title":["Mast cells drive IgE-mediated disease but might be bystanders in many other inflammatory and neoplastic conditions"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-481X","authenticated-orcid":false,"given":"Marcus","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas W.J.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Ebmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Roers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.07.017_bib1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.immuni.2018.04.025","article-title":"Hemogenic endothelial fate mapping reveals dual developmental origin of mast cells","volume":"48","author":"Gentek","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib2","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.1203420","article-title":"Innate immunity and its regulation by mast cells","volume":"190","author":"St John","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2015.07.017","article-title":"Non-IgE mediated mast cell activation","volume":"778","author":"Yu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2019.07.017_bib4","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1172\/JCI46139","article-title":"Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice","volume":"121","author":"Akahoshi","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib5","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3389\/fimmu.2018.01532","article-title":"Human mast cell tryptase is a potential treatment for snakebite envenoming across multiple snake species","volume":"9","author":"Anderson","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.1128877","article-title":"Mast cells can enhance resistance to snake and honeybee venoms","volume":"313","author":"Metz","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.017_bib7","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1084\/jem.20071262","article-title":"Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/2326-6066.CIR-13-0119","article-title":"Mast cells: potential positive and negative roles in tumor biology","volume":"1","author":"Marichal","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2015.09.002","article-title":"Mast cells and IgE in defense against venoms: possible \u201cgood side\u201d of allergy?","volume":"65","author":"Galli","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2019.07.017_bib10","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.192.12.1849","article-title":"Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1","volume":"192","author":"Knight","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib11","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1073\/pnas.1231488100","article-title":"Mast cells disrupt epithelial barrier function during enteric nematode infection","volume":"100","author":"McDermott","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.017_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-3024.1989.tb00667.x","article-title":"The action of a mast cell protease on the cuticular collagens of Necator americanus","volume":"11","author":"McKean","year":"1989","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/mi.2016.56","article-title":"Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection","volume":"10","author":"Reitz","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.immuni.2017.04.017","article-title":"Mast cells are crucial for induction of group 2 innate lymphoid cells and clearance of helminth infections","volume":"46","author":"Shimokawa","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.immuni.2016.11.003","article-title":"Loss of bladder epithelium induced by cytolytic mast cell granules","volume":"45","author":"Choi","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib16","doi-asserted-by":"crossref","first-page":"e0132367","DOI":"10.1371\/journal.pone.0132367","article-title":"Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in\u00a0vivo","volume":"10","author":"Ashina","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.07.017_bib17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2011.06.051","article-title":"Regulation of the immune response and inflammation by histamine and histamine receptors","volume":"128","author":"O'Mahony","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib18","doi-asserted-by":"crossref","first-page":"e2588","DOI":"10.1371\/journal.pntd.0002588","article-title":"the intestinal expulsion of the roundworm Ascaris suum is associated with eosinophils, intra-epithelial T cells and decreased intestinal transit time","volume":"7","author":"Masure","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.164.5.2006082","article-title":"Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa","volume":"164","author":"Braunstahl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3858\/emm.2011.43.1.004","article-title":"Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-alpha","volume":"43","author":"Chai","year":"2011","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/283666a0","article-title":"Immunisation against heterologous type II collagen induces arthritis in mice","volume":"283","author":"Courtenay","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.2003.12146.x","article-title":"Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid","volume":"120","author":"Dimson","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2018.00407","article-title":"The autoimmune skin disease bullous pemphigoid: the role of mast cells in autoantibody-induced tissue injury","volume":"9","author":"Fang","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/eji.201343731","article-title":"CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells","volume":"44","author":"Heger","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V10.5.467.467","article-title":"Distribution of histamine among leukocytes and platelets","volume":"10","author":"Graham","year":"1955","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2019.07.017_bib28","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","article-title":"Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data","volume":"7","author":"Bischoff","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(07)95006-3","article-title":"Mast cell proteases","volume":"95","author":"Pejler","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib31","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1073\/pnas.83.12.4464","article-title":"Two types of human mast cells that have distinct neutral protease compositions","volume":"83","author":"Irani","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.017_bib32","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.145.10.3432","article-title":"Failure to detect IL-3-binding sites on human mast cells","volume":"145","author":"Valent","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib33","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.4049\/jimmunol.145.6.1885","article-title":"IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites","volume":"145","author":"Valent","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib34","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/1521-4141(200208)32:8<2308::AID-IMMU2308>3.0.CO;2-X","article-title":"Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release","volume":"32","author":"Gebhardt","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib35","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1073\/pnas.96.14.8080","article-title":"IL-4 enhances proliferation and mediator release in mature human mast cells","volume":"96","author":"Bischoff","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.017_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri1460","article-title":"Mast-cell responses to pathogens","volume":"4","author":"Marshall","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2012.09.008","article-title":"New models for analyzing mast cell functions in\u00a0vivo","volume":"33","author":"Reber","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/335088a0","article-title":"The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus","volume":"335","author":"Chabot","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(90)90298-S","article-title":"Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles","volume":"63","author":"Copeland","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.07.017_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(88)90020-7","article-title":"The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene","volume":"55","author":"Geissler","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.07.017_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast cells in W\/Wv mice and their increase by bone marrow transplantation","volume":"52","author":"Kitamura","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib42","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1182\/blood.V93.11.3703","article-title":"Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors","volume":"93","author":"Sawai","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.1040730104","article-title":"Decreased neutrophils and megakaryocytes in anemic mice of genotype W\/W","volume":"73","author":"Chervenick","year":"1969","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaci.2019.07.017_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/373347a0","article-title":"W\/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity","volume":"373","author":"Huizinga","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib45","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2353\/ajpath.2008.080407","article-title":"Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy","volume":"173","author":"Nigrovic","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.07.017_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1074-7613(94)80015-4","article-title":"Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis","volume":"1","author":"Puddington","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","article-title":"Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens","volume":"34","author":"Dudeck","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2011.09.015","article-title":"Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity","volume":"35","author":"Feyerabend","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2011.11.004","article-title":"Mast cell deficiency, a game of kit and mouse","volume":"35","author":"Katz","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib50","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1182\/blood-2011-03-343962","article-title":"Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl\/fl mice","volume":"118","author":"Lilla","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib51","doi-asserted-by":"crossref","first-page":"e25538","DOI":"10.1371\/journal.pone.0025538","article-title":"Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity","volume":"6","author":"Otsuka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.07.017_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.201545613","article-title":"Mast cells have no impact on cutaneous leishmaniasis severity and related Th2 differentiation in resistant and susceptible mice","volume":"46","author":"Paul","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib53","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.celrep.2014.07.046","article-title":"IkappaB kinase 2 is essential for IgE-induced mast cell de novo cytokine production but not for degranulation","volume":"8","author":"Peschke","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2019.07.017_bib54","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/jid.2014.12","article-title":"Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis","volume":"134","author":"Willenborg","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2016.06.019","article-title":"Of mouse models of mast cell deficiency and metabolic syndrome","volume":"24","author":"Feyerabend","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2019.07.017_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2012.07.007","article-title":"Widespread immunological functions of mast cells: fact or fiction?","volume":"37","author":"Rodewald","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib57","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/eji.201040994","article-title":"Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function","volume":"41","author":"Dudeck","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.celrep.2017.12.010","article-title":"Although abundant in tumor tissue, mast cells have no effect on immunological micro-milieu or growth of hpv-induced or transplanted tumors","volume":"22","author":"Ghouse","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2019.07.017_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11248-007-9153-4","article-title":"Mast cell-specific Cre\/loxP-mediated recombination in\u00a0vivo","volume":"17","author":"Scholten","year":"2008","journal-title":"Transgenic Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib60","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.180.7.4742","article-title":"Homeostasis and effector function of lymphopenia-induced \u201cmemory-like\u201d T cells in constitutively T cell-depleted mice","volume":"180","author":"Voehringer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib61","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3389\/fimmu.2018.01870","article-title":"Unimpaired responses to vaccination with protein antigen plus adjuvant in mice with Kit-independent mast cell deficiency","volume":"9","author":"Schubert","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib62","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2014.10.005","article-title":"Dicer is indispensable for the development of murine mast cells","volume":"135","author":"Forster","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib63","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4049\/jimmunol.1101746","article-title":"Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness","volume":"188","author":"Sawaguchi","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib64","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.4049\/jimmunol.1301350","article-title":"Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis","volume":"191","author":"Antsiferova","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib65","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2016.00524","article-title":"No role for mast cells in obesity-related metabolic dysregulation","volume":"7","author":"Chmelar","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib66","doi-asserted-by":"crossref","first-page":"e85304","DOI":"10.1371\/journal.pone.0085304","article-title":"Mast cells play no role in the pathogenesis of postoperative ileus induced by intestinal manipulation","volume":"9","author":"Gomez-Pinilla","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.07.017_bib67","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.2337\/db14-0372","article-title":"Type 1 diabetes in NOD mice unaffected by mast cell deficiency","volume":"63","author":"Gutierrez","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2019.07.017_bib68","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2015.04.013","article-title":"Hematopoietic Kit deficiency, rather than lack of mast cells, protects mice from obesity and insulin resistance","volume":"21","author":"Gutierrez","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2019.07.017_bib69","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/nm.3646","article-title":"A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer","volume":"20","author":"Schonhuber","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib70","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.38996","article-title":"Mast cell promotion of T cell-driven antigen-induced arthritis despite being dispensable for antibody-induced arthritis in which T cells are bypassed","volume":"67","author":"Schubert","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib71","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI84598","article-title":"Megakaryocytes compensate for Kit insufficiency in murine arthritis","volume":"127","author":"Cunin","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib72","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jclinpath-2017-204881","article-title":"Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies?","volume":"71","author":"Malik","year":"2018","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2019.07.017_bib73","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2010.04.009","article-title":"Involvement of mast cells in eosinophilic esophagitis","volume":"126","author":"Abonia","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.01.033","article-title":"Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis","volume":"136","author":"Mashiko","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jaci.2016.01.017","article-title":"Repeated FcepsilonRI triggering reveals modified mast cell function related to chronic allergic responses in tissue","volume":"138","author":"Suurmond","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib78","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI112937","article-title":"Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness","volume":"79","author":"Casale","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib79","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198609253151304","article-title":"Release of prostaglandin D2 into human airways during acute antigen challenge","volume":"315","author":"Murray","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib80","doi-asserted-by":"crossref","first-page":"68990","DOI":"10.18632\/oncotarget.11837","article-title":"Mast cells promote melanoma colonization of lungs","volume":"7","author":"Ohrvik","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2019.07.017_bib81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1164\/ajrccm\/142.1.112","article-title":"Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge","volume":"142","author":"Wenzel","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib82","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200612-1814OC","article-title":"Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease","volume":"176","author":"Slats","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib84","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1056\/NEJM200209263471318","article-title":"Mast cells in airway smooth muscle","volume":"347","author":"Tunon-de-Lara","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib85","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94580","article-title":"Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias","volume":"2","author":"Gauthier","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.07.017_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib88","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1517\/14712598.2015.1084283","article-title":"Treatment of severe asthma: entering the era of targeted therapy","volume":"15","author":"van Buul","year":"2015","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.jaci.2019.07.017_bib89","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2222.1994.tb00920.x","article-title":"Attenuation of allergic airway inflammation in IL-4 deficient mice","volume":"24","author":"Brusselle","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-2222.2003.01588.x","article-title":"Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma","volume":"33","author":"Masuda","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaci.2007.02.046","article-title":"Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice","volume":"120","author":"Nakae","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.186.3.449","article-title":"Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice","volume":"186","author":"Takeda","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.192.3.455","article-title":"Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice","volume":"192","author":"Williams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib95","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.4049\/jimmunol.164.7.3855","article-title":"An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model","volume":"164","author":"Kobayashi","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib96","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.4049\/jimmunol.172.10.6398","article-title":"Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant","volume":"172","author":"Taube","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib97","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1172\/JCI25702","article-title":"Mast cells can promote the development of multiple features of chronic asthma in mice","volume":"116","author":"Yu","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib98","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/eji.200636612","article-title":"Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma","volume":"37","author":"Kim","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib99","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1183\/09031936.00058907","article-title":"Mast cell-derived tumour necrosis factor is essential for allergic airway disease","volume":"31","author":"Reuter","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.07.017_bib100","doi-asserted-by":"crossref","first-page":"e1001762","DOI":"10.1371\/journal.pbio.1001762","article-title":"A20-deficient mast cells exacerbate inflammatory responses in\u00a0vivo","volume":"12","author":"Heger","year":"2014","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2019.07.017_bib101","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.4049\/jimmunol.0900180","article-title":"Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation","volume":"183","author":"Waern","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib102","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1074\/jbc.M112.435156","article-title":"Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation","volume":"289","author":"Roy","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2019.07.017_bib103","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1398-9995.1990.tb00513.x","article-title":"The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent","volume":"45","author":"Ruhno","year":"1990","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apa.13151","article-title":"Breastfeeding and childhood acute otitis media: a systematic review and meta-analysis","volume":"104","author":"Bowatte","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaci.2019.07.017_bib105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2011.07.049","article-title":"Pathogenesis of chronic rhinosinusitis: inflammation","volume":"128","author":"Van Crombruggen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib106","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2500\/ajra.2013.27.3981","article-title":"Epidemiology and differential diagnosis of nasal polyps","volume":"27","author":"Chaaban","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib107","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000053811","article-title":"Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis","volume":"125","author":"Di Lorenzo","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4193\/Rhin17.139","article-title":"Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study","volume":"56","author":"Bidder","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2019.07.017_bib109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0003489417731782","article-title":"Anti-IgE and anti-IL5 biologic therapy in the treatment of nasal polyposis: a systematic review and meta-analysis","volume":"126","author":"Rivero","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaci.2019.07.017_bib110","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jaip.2017.04.024","article-title":"Biotherapeutics in chronic rhinosinusitis with and without nasal polyps","volume":"5","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2019.07.017_bib111","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2353\/ajpath.2010.090957","article-title":"Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract","volume":"176","author":"Moniaga","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.07.017_bib112","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib113","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.02.014","article-title":"Failure of omalizumab for treatment of severe adult atopic dermatitis","volume":"53","author":"Krathen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib114","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2005.09.030","article-title":"Treatment of recalcitrant atopic dermatitis with omalizumab","volume":"54","author":"Lane","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2222.2008.03007.x","article-title":"CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis","volume":"38","author":"Oiwa","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib116","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/jid.2013.250","article-title":"Mast cells are required for full expression of allergen\/SEB-induced skin inflammation","volume":"133","author":"Ando","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib117","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jid.2016.03.019","article-title":"Mast cells regulate epidermal barrier function and the development of allergic skin inflammation","volume":"136","author":"Sehra","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2019.07.017_bib119","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ajpath.2015.02.005","article-title":"Mast cells are dispensable in a genetic mouse model of chronic dermatitis","volume":"185","author":"Sulcova","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2019.07.017_bib120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature01324","article-title":"Mast cells in autoimmune disease","volume":"420","author":"Benoist","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib121","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev.immunol.26.021607.090320","article-title":"The master switch: the role of mast cells in autoimmunity and tolerance","volume":"26","author":"Sayed","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib122","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.coi.2010.08.015","article-title":"Mast cell mediators in tolerance","volume":"22","author":"de Vries","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib123","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.arcmed.2014.11.010","article-title":"Role of histaminergic system in blood\u2013brain barrier dysfunction associated with neurological disorders","volume":"45","author":"Banuelos-Cabrera","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-5728(90)90101-R","article-title":"Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains","volume":"30","author":"Toms","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(96)00102-6","article-title":"The mast cells of the multiple sclerosis brain","volume":"70","author":"Ibrahim","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.trsl.2014.08.005","article-title":"The meninges: new therapeutic targets for multiple sclerosis","volume":"165","author":"Russi","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-8118-10-19","article-title":"Elevated CSF histamine levels in multiple sclerosis patients","volume":"10","author":"Kallweit","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jaci.2019.07.017_bib128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.186.2.307","article-title":"Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease","volume":"186","author":"Lafaille","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0022-510X(94)90300-X","article-title":"Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in\u00a0vitro activation by myelin basic protein and neuropeptides","volume":"122","author":"Brenner","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jaci.2019.07.017_bib130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1471-4906(03)00233-3","article-title":"Involvement of both \u2018allergic\u2019 and \u2018autoimmune' mechanisms in EAE, MS and other autoimmune diseases","volume":"24","author":"Pedotti","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib131","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4049\/jimmunol.142.5.1476","article-title":"The role of mast cells in the elicitation of experimental allergic encephalomyelitis","volume":"142","author":"Dietsch","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib132","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.1003574","article-title":"Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis","volume":"186","author":"Sayed","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib133","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib134","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2009.08.022","article-title":"Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions","volume":"31","author":"Stelekati","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/labinvest.2011.3","article-title":"Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh\/W-sh mice","volume":"91","author":"Piconese","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib136","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4049\/jimmunol.1003603","article-title":"Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression","volume":"187","author":"Li","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib137","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.0801485","article-title":"Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis","volume":"182","author":"Bennett","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib138","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780270802","article-title":"Articular mastocytosis in rheumatoid arthritis","volume":"27","author":"Crisp","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.07.017_bib139","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.joca.2015.11.011","article-title":"Characterization of synovial mast cells in knee osteoarthritis: association with clinical parameters","volume":"24","author":"de Lange-Brokaar","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jaci.2019.07.017_bib140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17\u2013positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.07.017_bib141","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.57.11.664","article-title":"Synovial mast cell responses during clinical improvement in early rheumatoid arthritis","volume":"57","author":"Gotis-Graham","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib142","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.1780400314","article-title":"Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression","volume":"40","author":"Gotis-Graham","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.07.017_bib143","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ard.60.3.187","article-title":"Demonstration of mast cell chemotactic activity\u00a0in synovial fluid from rheumatoid patients","volume":"60","author":"Olsson","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib144","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13075-016-0970-9","article-title":"Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission","volume":"18","author":"Ramirez","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2019.07.017_bib145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/cs0930363","article-title":"Mast cell activation in arthritis: detection of \u03b1-and \u03b2-tryptase, histamine and eosinophil cationic protein in synovial fluid","volume":"93","author":"Buckley","year":"1997","journal-title":"Clin Sci"},{"key":"10.1016\/j.jaci.2019.07.017_bib146","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","article-title":"Organ-specific disease provoked by systemic autoimmunity","volume":"87","author":"Kouskoff","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.07.017_bib147","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","article-title":"Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme","volume":"286","author":"Matsumoto","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.017_bib148","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib149","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0047-6374(01)00371-2","article-title":"The molecular pathogenesis of collagen-induced arthritis in mice\u2014a model for rheumatoid arthritis","volume":"1","author":"Holmdahl","year":"2002","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jaci.2019.07.017_bib150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2007.08.001","article-title":"Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis","volume":"7","author":"Cho","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2019.07.017_bib151","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/art.22058","article-title":"Lymphocyte-independent connective tissue mast cells populate murine synovium","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2019.07.017_bib152","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s000110050467","article-title":"Increases in mast cells and chymase in fibroproliferative paws of collagen-induced arthritic mice","volume":"48","author":"Kakizoe","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib153","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"Mast cells: a cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.017_bib154","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.0610852103","article-title":"Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1","volume":"104","author":"Nigrovic","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.017_bib155","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1084\/jem.20071391","article-title":"Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis","volume":"204","author":"Zhou","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib156","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nprot.2008.19","article-title":"Protocol for the induction of arthritis in C57BL\/6 mice","volume":"3","author":"Inglis","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jaci.2019.07.017_bib157","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/ard.2010.134528","article-title":"Collagen-induced arthritis is not impaired in mast cell-deficient mice","volume":"70","author":"Pitman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib158","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1096\/fj.08-120394","article-title":"Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis","volume":"23","author":"Magnusson","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2019.07.017_bib159","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197802232980803","article-title":"Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid","volume":"298","author":"Wintroub","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib161","doi-asserted-by":"crossref","first-page":"936545","DOI":"10.1155\/2014\/936545","article-title":"Mediators of mast cells in bullous\u00a0pemphigoid and dermatitis herpetiformis","volume":"2014","author":"Zebrowska","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaci.2019.07.017_bib162","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1600-0625.2000.009002131.x","article-title":"Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies","volume":"9","author":"D'Auria","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib163","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/exd.13382","article-title":"Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid","volume":"26","author":"Bieber","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib164","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12026-014-8547-7","article-title":"Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid","volume":"59","author":"Messingham","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib165","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib166","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib167","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archdermatol.2012.1604","article-title":"Successful treatment of bullous pemphigoid with omalizumab","volume":"148","author":"London","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib168","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2011.10748.x","article-title":"Successful management of severe infant bullous pemphigoid with omalizumab","volume":"166","author":"Dufour","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib169","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Kenneth","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib170","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib171","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib172","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1074\/jbc.M111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2019.07.017_bib173","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib174","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.4049\/jimmunol.169.7.3987","article-title":"Macrophages, but not T and B lymphocytes, are critical for subepidermal blister\u00a0formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation","volume":"169","author":"Chen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib175","doi-asserted-by":"crossref","first-page":"37358","DOI":"10.1074\/jbc.M111.272401","article-title":"Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid","volume":"286","author":"Lin","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2019.07.017_bib176","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.173.11.6993","article-title":"Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat","volume":"173","author":"Hessner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib177","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.4049\/jimmunol.177.10.7275","article-title":"Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat","volume":"177","author":"Geoffrey","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.clim.2011.08.004","article-title":"Anti-FcepsilonR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice","volume":"141","author":"Hubner","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib179","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","article-title":"Macrophages, immunity, and metabolic disease","volume":"41","author":"McNelis","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.07.017_bib180","doi-asserted-by":"crossref","first-page":"E1677","DOI":"10.1210\/jc.2012-1532","article-title":"Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes","volume":"97","author":"Divoux","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2019.07.017_bib181","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.1994","article-title":"Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib182","first-page":"568","article-title":"Ketotifen in the treatment of diabetics with various allergic conditions","volume":"2","author":"Dolecek","year":"1981","journal-title":"Pharmatherapeutica"},{"key":"10.1016\/j.jaci.2019.07.017_bib183","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jdiacomp.2015.01.013","article-title":"Effect of ketotifen in obese patients with type 2 diabetes mellitus","volume":"29","author":"El-Haggar","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jaci.2019.07.017_bib184","first-page":"83","article-title":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib185","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib186","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","article-title":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Kiortsis","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib187","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib188","first-page":"83","article-title":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib189","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","article-title":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Kiortsis","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2019.07.017_bib190","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11892-015-0670-x","article-title":"Adipose tissue inflammation in the pathogenesis of type 2 diabetes","volume":"15","author":"Kohlgruber","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.jaci.2019.07.017_bib191","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jaci.2019.07.017_bib192","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11892-015-0670-x","article-title":"Adipose tissue inflammation in the pathogenesis of type 2 diabetes","volume":"15","author":"Kohlgruber","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jaci.2019.07.017_bib193","doi-asserted-by":"crossref","first-page":"C1360","DOI":"10.1152\/ajpcell.00514.2010","article-title":"Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2","volume":"301","author":"Tanaka","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jaci.2019.07.017_bib194","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00262-012-1246-0","article-title":"The roles of mast cells in anticancer immunity","volume":"61","author":"Dalton","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2019.07.017_bib195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10555-011-9286-z","article-title":"The significant role of mast cells in cancer","volume":"30","author":"Khazaie","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jaci.2019.07.017_bib196","first-page":"1541","article-title":"Mast cell-tumor cell interactions: for or against tumour growth and metastasis?","volume":"17","author":"Dimitriadou","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib197","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.it.2004.02.013","article-title":"Mast cells: the Jekyll and Hyde of tumor growth","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib198","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2008.06.001","article-title":"Mast cells and cancer\u2014no longer just basic science","volume":"68","author":"Galinsky","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaci.2019.07.017_bib199","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.07.017_bib200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijc.2910420110","article-title":"Mast-cell-deficient W\/Wv mice exhibit a decreased rate of tumor angiogenesis","volume":"42","author":"Starkey","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2019.07.017_bib201","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1101\/gad.13.11.1382","article-title":"Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis","volume":"13","author":"Coussens","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2019.07.017_bib202","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1649","article-title":"Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors","volume":"13","author":"Soucek","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib203","doi-asserted-by":"crossref","first-page":"e1004466","DOI":"10.1371\/journal.ppat.1004466","article-title":"HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells","volume":"10","author":"Bergot","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2019.07.017_bib204","doi-asserted-by":"crossref","first-page":"19977","DOI":"10.1073\/pnas.0704620104","article-title":"Mast cells are an essential hematopoietic component for polyp development","volume":"104","author":"Gounaris","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.07.017_bib205","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1158\/0008-5472.CAN-11-1637","article-title":"Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers","volume":"71","author":"Pittoni","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2019.07.017_bib206","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00262-012-1276-7","article-title":"Mast cells impair the development of protective anti-tumor immunity","volume":"61","author":"Wasiuk","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2019.07.017_bib207","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/labinvest.3700232","article-title":"Decreased susceptibility of mast cell-deficient Kit(W)\/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors","volume":"85","author":"Wedemeyer","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaci.2019.07.017_bib208","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/exd.12328","article-title":"Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model","volume":"23","author":"Siebenhaar","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib209","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib210","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA 2 LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib211","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0091-6749(88)90968-2","article-title":"Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation","volume":"82","author":"Ormerod","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib212","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","article-title":"Serum total tryptase levels are increased in patients with active chronic urticaria","volume":"40","author":"Ferrer","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib213","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/jid.2014.226","article-title":"Substance P is upregulated in the serum of patients with chronic spontaneous urticaria","volume":"134","author":"Metz","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.07.017_bib214","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejphar.2011.06.027","article-title":"G protein coupled receptor specificity for C3a and compound 48\/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2","volume":"668","author":"Kashem","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2019.07.017_bib215","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2016.07.047","article-title":"Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria","volume":"139","author":"Gericke","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib216","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jdermsci.2013.08.011","article-title":"Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis","volume":"73","author":"Metz","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2019.07.017_bib217","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2013a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2019.07.017_bib218","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib219","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-pathol-052016-100312","article-title":"Pathogenesis and pathology of mastocytosis","volume":"12","author":"Metcalfe","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2019.07.017_bib220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib221","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"kin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2019.07.017_bib222","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.07.017_bib223","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/all.13425","article-title":"Development and validation of the mastocytosis activity score","volume":"73","author":"Siebenhaar","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib224","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/all.13237","article-title":"Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations","volume":"73","author":"Broesby-Olsen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib225","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/all.12842","article-title":"Development and validation of the mastocytosis quality of life questionnaire: MC-QoL","volume":"71","author":"Siebenhaar","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.07.017_bib226","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2019.07.017_bib227","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.07.017_bib228","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOH.0000000000000486","article-title":"Novel approaches for systemic mastocytosis","volume":"26","author":"Fletcher","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2019.07.017_bib229","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2019.07.017_bib230","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.18632\/oncotarget.3074","article-title":"Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia","volume":"6","author":"Cerny-Reiterer","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2019.07.017_bib231","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ACI.0b013e32832e9af1","article-title":"Mast cells: makers and breakers of allergic inflammation","volume":"9","author":"Hakim-Rad","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919309650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919309650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:21:26Z","timestamp":1758792086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919309650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":231,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0091674919309650"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.07.017","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cells drive IgE-mediated disease but might be bystanders in many other inflammatory and neoplastic conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}